In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels

Iman Noshadi, Seonki Hong, Kelly E. Sullivan, Ehsan Shirzaei Sani, Roberto Portillo-Lara, Ali Tamayol, Su Ryon Shin, Albert E. Gao, Whitney L. Stoppel, Lauren D. Black, Ali Khademhosseini, Nasim Annabi

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Photocrosslinkable materials have been frequently used for constructing soft and biomimetic hydrogels for tissue engineering. Although ultraviolet (UV) light is commonly used for photocrosslinking such materials, its use has been associated with several biosafety concerns such as DNA damage, accelerated aging of tissues, and cancer. Here we report an injectable visible light crosslinked gelatin-based hydrogel for myocardium regeneration. Mechanical characterization revealed that the compressive moduli of the engineered hydrogels could be tuned in the range of 5-56 kPa by changing the concentrations of the initiator, co-initiator and co-monomer in the precursor formulation. In addition, the average pore sizes (26-103 μm) and swelling ratios (7-13%) were also shown to be tunable by varying the hydrogel formulation. In vitro studies showed that visible light crosslinked GelMA hydrogels supported the growth and function of primary cardiomyocytes (CMs). In addition, the engineered materials were shown to be biocompatible in vivo, and could be successfully delivered to the heart after myocardial infarction in an animal model to promote tissue healing. The developed visible light crosslinked hydrogel could be used for the repair of various soft tissues such as the myocardium and for the treatment of cardiovascular diseases with enhanced therapeutic functionality.

Original languageEnglish (US)
Pages (from-to)2093-2105
Number of pages13
JournalBiomaterials Science
Volume5
Issue number10
DOIs
StatePublished - Oct 2017

Fingerprint

Hydrogels
Hydrogel
Gelatin
Tissue
Biomimetics
Tissue engineering
Pore size
Swelling
Animals
Repair
Aging of materials
Monomers
DNA

ASJC Scopus subject areas

  • Biomedical Engineering
  • Materials Science(all)

Cite this

Noshadi, I., Hong, S., Sullivan, K. E., Shirzaei Sani, E., Portillo-Lara, R., Tamayol, A., ... Annabi, N. (2017). In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. Biomaterials Science, 5(10), 2093-2105. https://doi.org/10.1039/c7bm00110j

In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. / Noshadi, Iman; Hong, Seonki; Sullivan, Kelly E.; Shirzaei Sani, Ehsan; Portillo-Lara, Roberto; Tamayol, Ali; Shin, Su Ryon; Gao, Albert E.; Stoppel, Whitney L.; Black, Lauren D.; Khademhosseini, Ali; Annabi, Nasim.

In: Biomaterials Science, Vol. 5, No. 10, 10.2017, p. 2093-2105.

Research output: Contribution to journalArticle

Noshadi, I, Hong, S, Sullivan, KE, Shirzaei Sani, E, Portillo-Lara, R, Tamayol, A, Shin, SR, Gao, AE, Stoppel, WL, Black, LD, Khademhosseini, A & Annabi, N 2017, 'In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels', Biomaterials Science, vol. 5, no. 10, pp. 2093-2105. https://doi.org/10.1039/c7bm00110j
Noshadi, Iman ; Hong, Seonki ; Sullivan, Kelly E. ; Shirzaei Sani, Ehsan ; Portillo-Lara, Roberto ; Tamayol, Ali ; Shin, Su Ryon ; Gao, Albert E. ; Stoppel, Whitney L. ; Black, Lauren D. ; Khademhosseini, Ali ; Annabi, Nasim. / In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. In: Biomaterials Science. 2017 ; Vol. 5, No. 10. pp. 2093-2105.
@article{9bcfb62dcf06483dbb9cdf82b50daa1e,
title = "In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels",
abstract = "Photocrosslinkable materials have been frequently used for constructing soft and biomimetic hydrogels for tissue engineering. Although ultraviolet (UV) light is commonly used for photocrosslinking such materials, its use has been associated with several biosafety concerns such as DNA damage, accelerated aging of tissues, and cancer. Here we report an injectable visible light crosslinked gelatin-based hydrogel for myocardium regeneration. Mechanical characterization revealed that the compressive moduli of the engineered hydrogels could be tuned in the range of 5-56 kPa by changing the concentrations of the initiator, co-initiator and co-monomer in the precursor formulation. In addition, the average pore sizes (26-103 μm) and swelling ratios (7-13{\%}) were also shown to be tunable by varying the hydrogel formulation. In vitro studies showed that visible light crosslinked GelMA hydrogels supported the growth and function of primary cardiomyocytes (CMs). In addition, the engineered materials were shown to be biocompatible in vivo, and could be successfully delivered to the heart after myocardial infarction in an animal model to promote tissue healing. The developed visible light crosslinked hydrogel could be used for the repair of various soft tissues such as the myocardium and for the treatment of cardiovascular diseases with enhanced therapeutic functionality.",
author = "Iman Noshadi and Seonki Hong and Sullivan, {Kelly E.} and {Shirzaei Sani}, Ehsan and Roberto Portillo-Lara and Ali Tamayol and Shin, {Su Ryon} and Gao, {Albert E.} and Stoppel, {Whitney L.} and Black, {Lauren D.} and Ali Khademhosseini and Nasim Annabi",
year = "2017",
month = "10",
doi = "10.1039/c7bm00110j",
language = "English (US)",
volume = "5",
pages = "2093--2105",
journal = "Biomaterials Science",
issn = "2047-4830",
publisher = "Royal Society of Chemistry",
number = "10",

}

TY - JOUR

T1 - In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels

AU - Noshadi, Iman

AU - Hong, Seonki

AU - Sullivan, Kelly E.

AU - Shirzaei Sani, Ehsan

AU - Portillo-Lara, Roberto

AU - Tamayol, Ali

AU - Shin, Su Ryon

AU - Gao, Albert E.

AU - Stoppel, Whitney L.

AU - Black, Lauren D.

AU - Khademhosseini, Ali

AU - Annabi, Nasim

PY - 2017/10

Y1 - 2017/10

N2 - Photocrosslinkable materials have been frequently used for constructing soft and biomimetic hydrogels for tissue engineering. Although ultraviolet (UV) light is commonly used for photocrosslinking such materials, its use has been associated with several biosafety concerns such as DNA damage, accelerated aging of tissues, and cancer. Here we report an injectable visible light crosslinked gelatin-based hydrogel for myocardium regeneration. Mechanical characterization revealed that the compressive moduli of the engineered hydrogels could be tuned in the range of 5-56 kPa by changing the concentrations of the initiator, co-initiator and co-monomer in the precursor formulation. In addition, the average pore sizes (26-103 μm) and swelling ratios (7-13%) were also shown to be tunable by varying the hydrogel formulation. In vitro studies showed that visible light crosslinked GelMA hydrogels supported the growth and function of primary cardiomyocytes (CMs). In addition, the engineered materials were shown to be biocompatible in vivo, and could be successfully delivered to the heart after myocardial infarction in an animal model to promote tissue healing. The developed visible light crosslinked hydrogel could be used for the repair of various soft tissues such as the myocardium and for the treatment of cardiovascular diseases with enhanced therapeutic functionality.

AB - Photocrosslinkable materials have been frequently used for constructing soft and biomimetic hydrogels for tissue engineering. Although ultraviolet (UV) light is commonly used for photocrosslinking such materials, its use has been associated with several biosafety concerns such as DNA damage, accelerated aging of tissues, and cancer. Here we report an injectable visible light crosslinked gelatin-based hydrogel for myocardium regeneration. Mechanical characterization revealed that the compressive moduli of the engineered hydrogels could be tuned in the range of 5-56 kPa by changing the concentrations of the initiator, co-initiator and co-monomer in the precursor formulation. In addition, the average pore sizes (26-103 μm) and swelling ratios (7-13%) were also shown to be tunable by varying the hydrogel formulation. In vitro studies showed that visible light crosslinked GelMA hydrogels supported the growth and function of primary cardiomyocytes (CMs). In addition, the engineered materials were shown to be biocompatible in vivo, and could be successfully delivered to the heart after myocardial infarction in an animal model to promote tissue healing. The developed visible light crosslinked hydrogel could be used for the repair of various soft tissues such as the myocardium and for the treatment of cardiovascular diseases with enhanced therapeutic functionality.

UR - http://www.scopus.com/inward/record.url?scp=85030455787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030455787&partnerID=8YFLogxK

U2 - 10.1039/c7bm00110j

DO - 10.1039/c7bm00110j

M3 - Article

C2 - 28805830

AN - SCOPUS:85030455787

VL - 5

SP - 2093

EP - 2105

JO - Biomaterials Science

JF - Biomaterials Science

SN - 2047-4830

IS - 10

ER -